Lupus Nephritis Drug Voclosporin Shows Efficacy, Safety Over 3 Years
One study focused on patients with severe lupus nephritis, who are at greatest risk for kidney failure.
One study focused on patients with severe lupus nephritis, who are at greatest risk for kidney failure.
In a 5-year follow-up study, researchers identified the characteristics associated with cardiac function in patients with systemic lupus erythematosus.
In a study of 121 patients with lupus nephritis on dialysis, 26.4% experienced an SLE flare at a median of 17 months after dialysis initiation.
Risk increased progressively with the number of autoimmune diseases present and with younger age
Researchers compared the QRISK3 and the adjusted Global AntiPhospholipid Syndrome Score in patients with systemic lupus erythematosus to assess their risk of developing cardiovascular disease.
Most secondary end points did not support the results of the analysis for the primary end point
Persistent isolated C3 hypocomplementemia is associated with an increased risk for end-stage kidney disease or death in patients with proliferative lupus nephritis, a study revealed.
Researchers sought to integrate serum metabolomics and lipidomics to identify biomarkers of organ involvement in systemic lupus erythematosus.
Researchers evaluated the clinical value of miR-124-3p and miR-337-3p in plasma to determine whether they could serve as biomarkers for systemic lupus erythematosus.
Hypertension is prevalent among patients with lupus nephritis, especially in those with proliferative disease, investigators noted.